Terms: = Prostate cancer AND MUC16, CA125, CA-125 AND Staging
3 results:
1. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract] [Full Text] [Related]
2. Primary adenocarcinoma of the seminal vesicles. A review of the literature.
Katafigiotis I; Sfoungaristos S; Duvdevani M; Mitsos P; Roumelioti E; Stravodimos K; Anastasiou I; Constantinides CA
Arch Ital Urol Androl; 2016 Mar; 88(1):47-51. PubMed ID: 27072175
[TBL] [Abstract] [Full Text] [Related]
3. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
[TBL] [Abstract] [Full Text] [Related]
